| JYSZ2100514 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | License Renew | 2021-05-10 | | | | | view |
| JYSB2300087 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Supplementary Application | 2023-05-09 | | | | | view |
| CXSS2300004 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products(3.3) | New Drug Application | 2023-01-29 | | QILU Pharmaceutical Co Ltd | | | view |
| JXSL2101039 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products(2.1) | Import Drug Application | 2021-06-07 | | | | | view |
| JYSB2300066 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Supplementary Application | 2023-04-14 | | | | | view |
| JXSL2200083 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products(3.3) | Import Drug Application | 2022-06-13 | | | | | view |
| CXSL2101029 | 重组抗VEGF人源化单克隆抗体Fab片段注射液 | Ranibizumab | Injection | Biological Products(3.3) | New Drug Application | 2021-04-21 | | Jecho Biopharmaceuticals Co Ltd | | | view |
| JYSB2300065 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Supplementary Application | 2023-04-14 | | | | | view |
| JYSZ2200031 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | License Renew | 2022-07-06 | | | | | view |
| JYSB2300015 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Supplementary Application | 2023-02-03 | | | | | view |
| JYSB2200118 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Supplementary Application | 2022-07-07 | | | | | view |
| JTS1900020 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Disposable Import Drug Application | 2019-05-27 | Novartis Pharma Stein AG | Novartis Pharma Stein AG | Certificate Issued | 2019-06-19 | view |
| CXSL1700144 | CMAB818注射液 | Ranibizumab | Injection | Biological Products(2) | New Drug Application | 2018-01-08 | 上海百迈博制药有限公司 | Shanghai Biomabs Pharmaceuticals Co Ltd | Certificate Issued | 2018-07-06 | view |
| CXSL1700010 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products(2) | New Drug Application | 2017-07-03 | 上海联合赛尔生物工程有限公司 | Shanghai United Cell Biotechnology Co Ltd | In Review | 2017-06-30 | view |
| JXSL2000131 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products(3.3) | Import Drug Application | 2020-07-17 | 上海艾迈医疗科技有限公司 | 7 Items of Kangqiao Capital Questionnaire 2019q4 Affamedtherapeutics Limited | In Review | 2020-07-16 | view |
| JXSL1000041 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Import Drug Application | 2010-09-09 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2011-08-02 | view |
| JYSB1400195 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Supplementary Application | 2014-09-17 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2016-02-22 | view |
| JYSB1900120 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Supplementary Application | 2019-06-10 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2019-07-09 | view |
| JXSS1700003 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products | Import Drug Application | 2017-03-28 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2018-05-08 | view |
| JXSL0600043 | 雷珠单抗注射液 | Ranibizumab | Injection | Biological Products(7) | Import Drug Application | 2006-11-23 | 北京诺华制药有限公司 | Beijing Novartis Pharma Co Ltd | Certificate Issued | 2008-06-20 | view |
